Fill Finish Manufacturing Market Size and Forecasts (2020 – 2030)

Fill Finish Manufacturing Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product [Consumables (Prefilled Syringes, Glass Vials/Plastic Vials, Cartridges, and Others), and Instruments], Modality (Recombinant Proteins, Monoclonal Antibodies, Vaccines, Cell Therapies and Biological Therapies, Gene Therapies, and Others), and End User (Contract Manufacturing Organizations, Biopharmaceutical Companies, and Others)

Send Enquiry
Item ID: TIPRE00018228 Category: Tags: , ,

$3,633$6,433

Description

The fill-finish manufacturing market is expected to grow from US$ 8.705 billion in 2022 to US$ 17.165 billion by 2030; it is anticipated to record a CAGR of 8.9% from 2022 to 2030.
The term “fill/finish” describes the final steps of the manufacturing process, which are filling and finishing. Filling in the pharmaceutical industry means putting medication into a container and closing it, whereas finishing refers to sterilizing and standardizing medical supplies and containers.
Growing Adoption of Prefilled Syringes for Parenteral Administration drives the growth of the Fill Finish Manufacturing Market.
Parenteral administration is one of the most prominent routes chosen to stimulate immediate immune response and ensure the complete bioavailability of pharmaceutical products. A steady rise in the development and market availability of parenteral drugs has propelled the demand for advanced, cost-effective drug delivery devices that promise ease of administration. The benefits of prefilled syringes over traditional delivery systems include easy administration, improved safety, accurate dosing, and reduced contamination risks. Among drug delivery devices, prefilled syringes represent one of the fastest-growing primary packaging formats, which are designed for dose administration. In the past ten years, there has been an evident increase in the development of parenteral drugs (especially with the introduction of several classes of biologics), which has resulted in approximately three-fold increase in the consumption of prefilled syringes. The sustained preference for the prefilled syringes is attributed to the safety and ease of use of these products. Recent variants are designed with provisions to reduce errors in dosing, risk of occlusions, leakage of fluids (i.e., extravasation), and inflammation of veins (phlebitis). Owing to the benefits mentioned above, several injectable drugs—Humira, Enbrel, Avastin, PREVNAR 13, ALPROLIX, and Benefix, among others—diluents and other products requiring parenteral administration are packaged in prefilled syringes.
Over the past seven years, ~90 drugs have been approved in the prefilled syringe packaging form across different geographies, including North America, Europe, and Asia Pacific. Several drugs in the clinical stages of drug development are being evaluated in combination with prefilled syringes.
The loading of sterile drugs into prefilled syringes is considered one of the most crucial steps in the pharmaceutical production process. Proper fill-finish operations are necessarily carried out under aseptic conditions to maintain pharmacological efficacy and quality and to ensure the safety of end users. The prefilled syringe filling is a complex operation as it requires extremely close monitoring of both the syringe fill volume and the headspace between the liquid filled in the syringe and the bottom of the plunger. In addition, the rise in complexity of small molecule APIs and the increasing diversity of biological drugs contribute to the demand for advanced aseptic fill finish operations.
Companies, including small enterprises and large businesses, outsource their respective fill finish operations to contract service providers. Per the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, manufacturers of biological have been observed to outsource more than 30% of their fill finish operations. With the rise in the demand for prefilled syringes and the growing complexity of fill finish processes, outsourcing these operations is likely to increase in the future. Over 100 companies across the globe are providing fill finish services for prefilled syringe manufacturers. To cater to the growing demand for pharmaceutical products, service providers are actively investing in expanding their existing infrastructure and capabilities; they have also expanded their clientele through service agreements over the past few years. As injectables account for ~55% of drug candidates in the global R&D pipeline, the businesses of prefilled syringe manufacturers and associated service providers are also growing. Due to the emergence of the COVID-19 crisis, vaccine development initiatives have increased across the globe, which significantly boosted the demand for prefilled syringes. Thus, the rising adoption of prefilled syringes for parenteral administration drives the fill finish manufacturing market.
The fill finish manufacturing market is divided on the basis of product, modality, and end user. Based on product, the fill finish manufacturing market is segmented into consumables and instruments. The consumables segment is further divided into prefilled syringes, glass vials/plastic vials, cartridges, and others. By modality, the fill finish manufacturing market is segmented into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. In terms of end users, the fill finish manufacturing market is classified as contract manufacturing organizations, biopharmaceutical companies, and others.
Based on geography, the fill finish manufacturing market is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of the fill finish manufacturing market. Canada is among the fastest-developing countries in terms of the biopharmaceutical industry. Various international companies are investing in the Canadian biopharmaceutical industry. In Canada, the number of biopharmaceutical companies is rising significantly. For instance, Vancouver, British Columbia, has the majority of biopharmaceutical companies, which generate US$ 90.3 million (CAD 120 million) revenue annually. There are ~35–40 domestic biopharmaceutical companies across the country. A few of the Canadian biopharmaceutical companies include Inex Pharmaceuticals, Quest Vitamins, StressGen Biotechnologies, Stanley Pharmaceuticals, QLT Phototherapeutics, and Stemcell Technologies. Various public and private research organizations include the Center for Molecular Medicine and Therapeutics, the Biotechnology Laboratory at the University of British Columbia, the BC Cancer Research Center, the Canadian HIV Trials Network, and the Vaccine Evaluation Center. Thus, the development of the biopharmaceutical industry in the country will bolster the market growth during the forecast period
Asia Pacific is expected to be the fastest-growing market in the coming years. In Asia Pacific, China is the largest market for fill finish manufacturing. The growth of the market is primarily attributed to the rising technological advancements in fill finish manufacturing processes in China, increasing developments by the market players, the biopharmaceutical industry’s expansion, and the growing prevalence of chronic diseases. There are more than 500 biological product/biopharmaceutical companies in China. Most of those involved in R&D were established by returnees from abroad or by Western/joint venture companies. Although estimates vary widely, analysts believe that the Chinese government spends more than US$ 600 million annually on biotech R&D through its funding initiatives. China’s national and local governments also invest in quasi-venture capital companies that invest in IT enterprises. The market players are expanding their business through organic and inorganic growth strategies. For instance, WuXi Biologics increased the capacity of prefilled syringes (PFS) to 17 million units yearly in June 2022 by opening its drug product factory in Wuxi, China. The most recent D.P. facility operated by WuXi Bio, a contract development manufacturing organization (CDMO), is called DP5, and it has an advanced isolator filling line for reliable, continuous filling services. According to the company, this provides PFS with a variety of volume delivery options, including 1.25 mL, 3 mL, 1 mL, and 1 mL.
ClinicalTrails.com, Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA) are a few key primary and secondary sources referred to while preparing the report on the fill finish manufacturing market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

Consumables Segment, by Product, to Account Larger Share Fill Finish Manufacturing Market During 2022–2030

According to our new research study on “Fill Finish Manufacturing Market Size and Forecast (2020–2030), Global and Regional Share, Trends, and Growth Opportunity Analysis,” the fill finish manufacturing market size is expected to grow from US$ 8.705 billion in 2022 and to reach a value of US$ 17.165 billion by 2030; it is anticipated to record a CAGR of 8.9% from 2022 to 2030. Key factors driving the market growth are the growing adoption of prefilled syringes for parenteral administration and elevating demand for biologics. However, growing competition in the biopharmaceutical contract manufacturing industry hinders the fill finish manufacturing market growth.

Parenteral administration is one of the most prominent routes chosen to stimulate immediate immune response and ensure the complete bioavailability of pharmaceutical products. A steady rise in the development and market availability of parenteral drugs has propelled the demand for advanced, cost-effective drug delivery devices that promise ease of administration. The benefits of prefilled syringes over traditional delivery systems include easy administration, improved safety, accurate dosing, and reduced contamination risks. Among drug delivery devices, prefilled syringes represent one of the fastest-growing primary packaging formats, which are designed for dose administration. In the past ten years, there has been an evident increase in the development of parenteral drugs (especially with the introduction of several classes of biologics), which has resulted in approximately three-fold increase in the consumption of prefilled syringes. The sustained preference for the prefilled syringes is attributed to the safety and ease of use of these products. Recent variants are designed with provisions to reduce errors in dosing, risk of occlusions, leakage of fluids (i.e., extravasation), and inflammation of veins (phlebitis). Owing to the benefits mentioned above, several injectable drugs—Humira, Enbrel, Avastin, PREVNAR 13, ALPROLIX, and Benefix, among others—diluents and other products requiring parenteral administration are packaged in prefilled syringes.
Over the past seven years, ~90 drugs have been approved in the prefilled syringe packaging form across different geographies, including North America, Europe, and Asia Pacific. Several drugs in the clinical stages of drug development are being evaluated in combination with prefilled syringes.
The loading of sterile drugs into prefilled syringes is considered one of the most crucial steps in the pharmaceutical production process. Proper fill-finish operations are necessarily carried out under aseptic conditions to maintain pharmacological efficacy and quality and to ensure the safety of end users. The prefilled syringe filling is a complex operation as it requires extremely close monitoring of both the syringe fill volume and the headspace between the liquid filled in the syringe and the bottom of the plunger. In addition, the rise in complexity of small molecule APIs and the increasing diversity of biological drugs contribute to the demand for advanced aseptic fill finish operations.
Companies, including small enterprises and large businesses, outsource their respective fill finish operations to contract service providers. Per the 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, manufacturers of biological have been observed to outsource more than 30% of their fill finish operations. With the rise in the demand for prefilled syringes and the growing complexity of fill finish processes, outsourcing these operations is likely to increase in the future. Over 100 companies across the globe are providing fill finish services for prefilled syringe manufacturers. To cater to the growing demand for pharmaceutical products, service providers are actively investing in expanding their existing infrastructure and capabilities; they have also expanded their clientele through service agreements over the past few years. As injectables account for ~55% of drug candidates in the global R&D pipeline, the businesses of prefilled syringe manufacturers and associated service providers are also growing. Due to the emergence of the COVID-19 crisis, vaccine development initiatives have increased across the globe, which significantly boosted the demand for prefilled syringes. Thus, the rising adoption of prefilled syringes for parenteral administration drives the fill finish manufacturing market.

Based on product, the fill finish manufacturing market is segmented into Consumables and Instruments. The Consumables segment is further bifurcated into prefilled syringes, glass vial/plastic vials, cartridges, and others. The increase in the number of biotechnology firms worldwide, advances in life science research and technology innovations with human genome mapping, and the emergence of proteomics have enabled industry growth, such as high-end research projects that require quality instruments with high throughput capacity are the key factors fueling the segment growth. However, the presence of alternative technologies and the high cost of instruments are a few factors hampering the growth of this segment in the fill finish manufacturing market.

Based on the modality, the fill finish manufacturing market is classified into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. Vaccine fill finish manufacturing is a critical stage in the production process. It involves filling vials with the prepared vaccine and ensuring precise quantities. This step demands stringent quality control to maintain efficacy and safety. Once filled, the vials undergo sealing and packaging. This meticulous process plays a pivotal role in delivering vaccines to the global population, safeguarding public health by meeting quality standards and regulatory requirements.
Furthermore, increasing key development related to vaccine fill finish manufacturing is driving the market growth. For instance, in May 2023, Novocol Pharma—a leading sterile injectable contract development and manufacturing organization (CDMO) in Ontario—and Moderna, Inc.—a biotechnology company that pioneered messenger RNA (mRNA) therapeutics and vaccines—announced a long-term agreement to perform aseptic fill finish, labeling, and packaging of mRNA respiratory vaccines expected to be produced in Canada. The last stage of the production cycle, known as fill-finish sterile manufacturing, entails putting the vaccine medication product into vials and preparing it for use. Furthermore, the arrangement with Novocol Pharma will increase the fill finish capacity of vaccines produced at Moderna’s mRNA facility in Laval. Subject to planning and regulatory permissions, the facility is anticipated to open for business by the end of 2024

Based on the end user, the fill finish manufacturing market is classified into contract manufacturing organizations, biopharmaceutical companies, and others. Companies engaged in therapeutics development often address the challenge of product stability and cold-chain management. At commercial scale, many problems can occur that might affect the therapeutic capabilities of the product. These factors are driving the adoption of commercial manufacturing services. Also, many industrial players offer commercial manufacturing services to overcome these issues. For instance, Piramal Pharma Solutions manufactures, supplies, and distributes commercial formulations from its facilities in the UK and India. They offer scalability services for commercial-level manufacturing of a wide range of pharmaceutical products.

IMA Industria Macchine Automatiche SpA, Nipro Medical Europe NV, Maquinaria Industrial Dara SL, Groninger and Co GmbH, SGD SA, Optima Packaging Group Gmbh, NNE AS, Stevanato Group SpA, Syntegon Technology GmbH, West Pharmaceutical Services Inc, Gerresheimer AG, Schott AG, and Becton Dickinson and Co. are among the leading companies operating in the global fill finish manufacturing market.

Companies operating in fill finish manufacturing adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies in the fill finish manufacturing. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall fill finish manufacturing growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

A few of the significant developments by key market players are listed below.

• In February 2023, Gerresheimer and Corning announced a joint venture to meet the growing demand for Velocity Vials. The partnership will combine Gerresheimer’s extensive glass converting expertise with Corning’s Velocity Vial technology platform, helping set a new standard for the industry. Pharmaceutical companies will benefit from improved filling line performance with increased throughput and yield, lowering their total cost of ownership.
• In July 2023, Syntegon launched its GKF Capsylon 6005 in capsule filling for the nutraceutical industry. It has 360,000 filled capsules per hour thanks to 48 segment bores and two dosing stations. It has higher product yield and minimized dust impact due to patented slide-gate technology.

?
About The Insight Partners

The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as healthcare, media, and telecommunication.

Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis.

Our research content is majorly focused on market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, type, end users, etc., which helps our clients to gain a deeper analytical understanding of various research topics.

Contact Us
If you have any queries about this report or would like further information, please contact us:

? North America: +1 646 491 9876
? Asia Pacific: +91 20 6727 8686
? Email: sales@theinsightpartners.com

Disclaimer
All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the publisher, “The Insight Partners.”

The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that the findings, conclusions, and recommendations that “The Insight Partners” delivers will be based on information gathered in good faith from primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such, “The Insight Partners” can accept no liability whatsoever for actions taken based on any information that may subsequently prove to be incorrect.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Encapsulated Fragrances Market, by Product Type
1.3.2 Asia Pacific Encapsulated Fragrances Market, by Application
1.3.3 Asia Pacific Encapsulated Fragrances Market, by Country
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.1.1 Asia Pacific Encapsulated Fragrances Market, by Product Type, and Application
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis formulation:
3.2.4 Macro-economic factor analysis:
3.2.5 Developing base number:
3.2.6 Data Triangulation:
3.2.7 Country level data:
4. Asia Pacific Encapsulated Fragrances Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers:
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
4.3.1 Overview:
4.3.2 Raw Material Suppliers:
4.3.3 Manufacturers
4.3.4 Distributors
4.3.5 End-User
4.4 Expert Opinion
5. Asia Pacific Encapsulated Fragrances Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Adoption of Encapsulated Fragrances from Various Applications
5.1.2 Strategic Initiatives by Key Market Players
5.2 Market Restraints
5.2.1 High Costs Associated with Encapsulation Technology
5.3 Market Opportunities
5.3.1 Rising Innovations in Encapsulation Technology
5.4 Future Trends
5.4.1 Increasing Demand for Natural Fragrances
5.5 Impact Analysis
6. Encapsulated Fragrances – Asia Pacific Market Analysis
6.1 Asia Pacific Encapsulated Fragrances Market -Revenue and Forecast to 2028 (US$ Mn)
6.2 Asia Pacific Encapsulated Fragrances Market -Volume and Forecast to 2028 (Kilotons)
7. Asia Pacific Encapsulated Fragrances Market Analysis – By Product Type
7.1 Overview
7.2 Asia Pacific Encapsulated Fragrances Market, By Product Type (2022 and 2028)
7.3 Fragrance Blends
7.3.1 Overview
7.3.2 Fragrance Blends: Asia Pacific Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
7.3.3 Fragrance Blends: Asia Pacific Encapsulated Fragrances Market -Volume and Forecast to 2028 (Kilotons)
7.4 Aroma Chemicals
7.4.1 Overview
7.4.2 Aroma Chemicals: Asia Pacific Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
7.4.3 Aroma Chemicals: Asia Pacific Encapsulated Fragrances Market -Volume and Forecast to 2028 (Kilotons)
7.5 Others
7.5.1 Overview
7.5.2 Others: Asia Pacific Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
7.5.3 Others: Asia Pacific Encapsulated Fragrances Market -Volume and Forecast to 2028 (Kilotons)
8. Asia Pacific Encapsulated Fragrances Market Analysis – By Application
8.1 Overview
8.2 Asia Pacific Encapsulated Fragrances Market, By Application (2022 and 2028)
8.3 Perfumes and Fragrances
8.3.1 Overview
8.3.2 Perfumes and Fragrances: Asia Pacific Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
8.4 Cleaning Products
8.4.1 Overview
8.4.2 Cleaning Products: Asia Pacific Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
8.5 Cosmetics
8.5.1 Overview
8.5.2 Cosmetics: Asia Pacific Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
8.6 Personal Hygiene Products
8.6.1 Overview
8.6.2 Personal Hygiene Products: Asia Pacific Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
8.7 Food and Beverages
8.7.1 Overview
8.7.2 Food and Beverages: Asia Pacific Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Others: Asia Pacific Encapsulated Fragrances Market – Revenue and Forecast to 2028 (US$ Mn)
9. Asia Pacific Encapsulated Fragrances Market – Country Analysis
9.1 Overview
9.1.1 Asia-Pacific: Encapsulated Fragrances Market, by Key Country
9.1.1.1 Australia: Encapsulated Fragrances Market -Analysis and Forecast to 2028 (US$ Million)
9.1.1.1.1 Australia: Encapsulated Fragrances Market, by Product Type
9.1.1.1.2 Australia: Encapsulated Fragrances Market, by Application
9.1.1.2 China: Encapsulated Fragrances Market -Analysis and Forecast to 2028 (US$ Million)
9.1.1.2.1 China: Encapsulated Fragrances Market, by Product Type
9.1.1.2.2 China: Encapsulated Fragrances Market, by Application
9.1.1.3 India: Encapsulated Fragrances Market -Analysis and Forecast to 2028 (US$ Million)
9.1.1.3.1 India: Encapsulated Fragrances Market, by Product Type
9.1.1.3.2 India: Encapsulated Fragrances Market, by Application
9.1.1.4 Japan: Encapsulated Fragrances Market -Analysis and Forecast to 2028 (US$ Million)
9.1.1.4.1 Japan: Encapsulated Fragrances Market, by Product Type
9.1.1.4.2 Japan: Encapsulated Fragrances Market, by Application
9.1.1.5 South Korea: Encapsulated Fragrances Market -Analysis and Forecast to 2028 (US$ Million)
9.1.1.5.1 South Korea: Encapsulated Fragrances Market, by Product Type
9.1.1.5.2 South Korea: Encapsulated Fragrances Market, by Application
9.1.1.6 ASEAN: Encapsulated Fragrances Market -Analysis and Forecast to 2028 (US$ Million)
9.1.1.6.1 ASEAN: Encapsulated Fragrances Market, by Product Type
9.1.1.6.2 ASEAN: Encapsulated Fragrances Market, by Application
9.1.1.7 Rest of Asia-Pacific: Encapsulated Fragrances Market -Analysis and Forecast to 2028 (US$ Million)
9.1.1.7.1 Rest of Asia-Pacific: Encapsulated Fragrances Market, by Product Type
9.1.1.7.2 Rest of Asia-Pacific: Encapsulated Fragrances Market, by Application
10. Industry Landscape
10.1 Overview
10.2 Expansion
10.3 New Product Development
10.4 Merger and Acquisition
11. Company Profiles
11.1 Firmenich SA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Givaudan SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Ingredion Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 International Flavors & Fragrances Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Symrise AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Glatt GmbH
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Insilico Medicine Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Follmann GmbH & Co KG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Ashland Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About
12.2 Glossary of Terms

LIST OF TABLES

Table 1. Fill Finish Manufacturing Market Segmentation
Table 2. Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Million) – Product
Table 3. Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Million) – Consumables
Table 4. Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Million) – Modality
Table 5. Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Million) – End User
Table 6. North America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 7. North America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 8. North America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 9. North America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 10. United States Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 11. United States Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 12. United States Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 13. United States Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 14. Canada Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 15. Canada Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 16. Canada Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 17. Canada Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 18. Mexico Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 19. Mexico Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 20. Mexico Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 21. Mexico Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 22. Europe Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 23. Europe Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 24. Europe Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 25. Europe Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 26. United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 27. United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 28. United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 29. United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 30. Germany Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 31. Germany Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 32. Germany Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 33. Germany Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 34. France Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 35. France Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 36. France Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 37. France Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 38. Italy Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 39. Italy Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 40. Italy Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 41. Italy Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 42. Spain Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 43. Spain Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 44. Spain Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 45. Spain Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 46. Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 47. Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 48. Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 49. Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 50. Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 51. Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 52. Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 53. Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 54. China Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 55. China Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 56. China Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 57. China Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 58. Japan Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 59. Japan Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 60. Japan Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 61. Japan Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 62. India Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 63. India Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 64. India Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 65. India Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 66. Australia Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 67. Australia Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 68. Australia Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 69. Australia Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 70. South Korea Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 71. South Korea Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 72. South Korea Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 73. South Korea Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 74. Rest of APAC Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 75. Rest of APAC Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 76. Rest of APAC Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 77. Rest of APAC Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 78. Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 79. Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 80. Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 81. Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 82. South Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 83. South Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 84. South Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 85. South Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 86. Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 87. Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 88. Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 89. Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 90. United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 91. United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 92. United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 93. United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 94. Rest of Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 95. Rest of Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 96. Rest of Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 97. Rest of Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 98. South and Central America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 99. South and Central America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 100. South and Central America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 101. South and Central America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 102. Brazil Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 103. Brazil Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 104. Brazil Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 105. Brazil Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 106. Argentina Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 107. Argentina Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 108. Argentina Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 109. Argentina Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 110. Rest of South and Central America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Product
Table 111. Rest of South and Central America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Consumables
Table 112. Rest of South and Central America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By Modality
Table 113. Rest of South and Central America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn) – By End User
Table 114. Recent Inorganic Growth Strategies in the Fill Finish Manufacturing Market
Table 115. Recent Organic Growth Strategies in The Fill Finish Manufacturing Market
Table 116. Glossary of Terms, Fill Finish Manufacturing Market

LIST OF FIGURES

Figure 1. Fill Finish Manufacturing Market Segmentation, By Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Fill Finish Manufacturing Market Revenue (US$ Million), 2022 – 2030
Figure 5. Fill Finish Manufacturing Market Share (%) – Product, 2022 and 2030
Figure 6. Consumables Market Revenue and Forecasts To 2030 (US$ Million)
Figure 7. Instruments Market Revenue and Forecasts To 2030 (US$ Million)
Figure 8. Fill Finish Manufacturing Market Share (%) – Modality, 2022 and 2030
Figure 9. Recombinant Proteins Market Revenue and Forecasts To 2030 (US$ Million)
Figure 10. Monoclonal Antibodies Market Revenue and Forecasts To 2030 (US$ Million)
Figure 11. Vaccines Market Revenue and Forecasts To 2030 (US$ Million)
Figure 12. Cell Therapies and Biological Therapies Market Revenue and Forecasts To 2030 (US$ Million)
Figure 13. Gene Therapies Market Revenue and Forecasts To 2030 (US$ Million)
Figure 14. Others Market Revenue and Forecasts To 2030 (US$ Million)
Figure 15. Fill Finish Manufacturing Market Share (%) – End User, 2022 and 2030
Figure 16. Contract Manufacturing Organizations Market Revenue and Forecasts To 2030 (US$ Million)
Figure 17. Biopharmaceutical Companies Market Revenue and Forecasts To 2030 (US$ Million)
Figure 18. Others Market Revenue and Forecasts To 2030 (US$ Million)
Figure 19. Fill Finish Manufacturing Market Breakdown by Region, 2022 and 2030 (%)
Figure 20. North America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 21. North America Fill Finish Manufacturing Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 22. US Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 23. Canada Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 24. Mexico Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 25. Europe Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 26. Europe Fill Finish Manufacturing Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 27. United Kingdom Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 28. Germany Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 29. France Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 30. Italy Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 31. Spain Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 32. Rest of Europe Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 33. Asia Pacific Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 34. Asia Pacific Fill Finish Manufacturing Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 35. China Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 36. Japan Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 37. India Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 38. Australia Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 39. South Korea Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 40. Rest of APAC Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 41. Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 42. Middle East and Africa Fill Finish Manufacturing Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 43. South Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 44. Saudi Arabia Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 45. United Arab Emirates Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 46. Rest of Middle East and Africa Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 47. South and Central America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 48. South and Central America Fill Finish Manufacturing Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 49. Brazil Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 50. Argentina Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 51. Rest of South and Central America Fill Finish Manufacturing Market Revenue and Forecasts To 2030 (US$ Mn)
Figure 52. Growth Strategies in The Fill Finish Manufacturing Market, 2020-2023

The List of Companies – Fill Finish Manufacturing Market
– IMA Industria Macchine Automatiche SpA
– Nipro Medical Europe NV
– Maquinaria Industrial Dara SL
– Groninger and Co GmbH
– SGD SA
– Optima Packaging Group Gmbh
– NNE AS
– Stevanato Group SpA
– Syntegon Technology GmbH
– West Pharmaceutical Services Inc
– Gerresheimer AG
– Schott AG
– Becton Dickinson and Co

Reviews

There are no reviews yet.

Be the first to review “Fill Finish Manufacturing Market Size and Forecasts (2020 – 2030)”